Neuroligin-3 stimulates many carcinogenic pathways, not only upregulating synapse-related genes, enabling neurons to communicate synaptically with gliomas to promote glioma growth, but also promoting GBM proliferation by activating PI3K as a mitogen [92,93,94,95]. The gene discussed is NLGN3; the disease is central nervous system cancer.